Literature DB >> 7839468

Usefulness of the Nd:YAG laser in parenchyma-sparing resection of pulmonary nodular lesions.

T C Mineo1, B Cristino, V Ambrogi, G L Natali, C U Casciani.   

Abstract

AIMS AND
BACKGROUND: The neodymium:yttrium-aluminium-garnet (Nd:YAG) laser has been successfully employed in parenchyma-sparing resection of pulmonary nodular lesions. We report our experience with limited resection using a noncontact Nd:YAG laser applied through a thoracotomic approach.
METHODS: During the period March 1987-October 1993, we performed parenchyma-sparing resections of 66 pulmonary nodular lesions with a noncontact Nd:YAG laser in 47 patients. Nodules were approached through postero-lateral thoracotomy (n = 40), median sternotomy (n = 5) or staged bilateral thoracotomy (n = 2). Fifty-two lesions were located in a peripheral position and the others (n = 14) at various depths within the parenchyma.
RESULTS: Fifteen lesions were benign: hamartoma (n = 5), chronic pneumonic infiltrate (n = 3), tuberculoma (n = 3), asbestosis (n = 2), Wegener's granuloma (n = 1). Twelve lesions were attributable to primary lung cancer and 33 were metastatic lesions. Another 6 lesions turned out to be necrotic metastases following chemotherapy. There were no perioperative deaths. Pulmonary re-expansion was shortly obtained: mean drainage time was 4.31 +/- 3.9 days. Only one patient presented a prolonged drainage time (11 days); in this case, the air leak was successfully treated by tissue glue sealant trans-drainage infiltration. Follow-up ranged from 2 to 96 months. No case of relapse on the resection site has been observed.
CONCLUSIONS: The results suggest that Nd:YAG laser resection is safe and worthwhile in patients with multiple lesions and borderline pulmonary function.

Entities:  

Mesh:

Year:  1994        PMID: 7839468     DOI: 10.1177/030089169408000511

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  2 in total

1.  Laser application enables awake thoracoscopic resection of pulmonary nodules with minimal access.

Authors:  Thomas G Lesser
Journal:  Surg Endosc       Date:  2011-11-01       Impact factor: 4.584

2.  Uniportal non-intubated lung metastasectomy.

Authors:  Tommaso Claudio Mineo; Francesco Sellitri; Eleonora Fabbi; Vincenzo Ambrogi
Journal:  J Vis Surg       Date:  2017-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.